CDK2 inhibitors: rationally directed discovery of a novel potent lead derived from cyclohepta[e]thieno[2,3-b]pyridine.

seliciclib (CYC202) - Cyclacel, Cedars-Sinai

http://www.ncbi.nlm.nih.gov/pubmed/40823493

Etify A Bakhite; Hajjaj H M Abdu-Allah; Omaima F Ibrahim; Raed M Maklad; Yasmin M Syam

Aug 18, 2025